Analysts Defend Abbott Labs' Stock After Thursday's 'Too Punitive' Sell-Off
3 Articles
3 Articles
Abbott Laboratories (NYSE:ABT) Stock Price Expected to Rise, Mizuho Analyst Says
Abbott Laboratories (NYSE:ABT – Free Report) had its price objective raised by Mizuho from $130.00 to $140.00 in a research note released on Wednesday,Benzinga reports. They currently have a neutral rating on the healthcare product maker’s stock. Several other research firms have also weighed in on ABT. Morgan Stanley raised their target price on Abbott […]
Abbott Laboratories (NYSE:ABT) Shares Acquired by Woodward Diversified Capital LLC
Woodward Diversified Capital LLC lifted its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 4.4% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 4,639 shares of the healthcare product maker’s stock after acquiring an additional 195 shares during the quarter. […]
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium